BLOCK-HF试验证明,在纽约心功能分级(NYHA)I至III级心力衰竭、LVEF≤50%和房室传导阻滞患者中,CRT优于常规右心室起搏。该试验纳入的患者被随机分配接受右心室起搏或CRT,结果显示CRT组的主要结局(死亡、因心衰紧急就诊或左心室收缩末期容积增加15%)发生率降低。 医脉通编译自:Handa R, Jeyashanmugaraja GP, Stroud...
CHILDRENized,placebo-controlledclinicaltrialsinadultswithHF associatedwithreducedLVejectionfractionfoundthat DilatedCardiomyopathycertaindrugsreducedtheincidenceofhospitalization StrategiesforTreatingPediatricDCMandmortality.Thesedrugsareangiotensin-converting RecentAHAguidelineshaveproposeda4-stagesystemenzyme(ACE)inhibitorsorangi...
been incorporated into the most recent HF guidelines 2 : HFrEF includes patients with an EF ≤40%; HF with mildly reduced EF (HFmrEF) includes those with an EF of 41% to 49%; and HFpEF includes those with an EF ≥50%. 1 Epidemiology of HFpEF HFpEF affects approximately half of all p...
心力衰竭(heart failure,HF,简称心衰)是指心脏结构或功能异常导致心室收缩或充盈障碍引起的症状和体征的复杂临床综合征[1]。2022年美国心脏病学会(American College of Cardiology,ACC)/美国心脏协会(American Heart Association,AHA)/美国心力衰竭协会(Heart Failure Society of America,HFSA)《心力衰竭管理指南》(简称《...
guidelines include recommendations relevant to HF and, in such cases, the HF guideline refers to these documents. For example, the 2019 primary prevention of cardiovas- cular disease guideline (3) includes recommendations that will be useful in preventing HF, and the 2021 valvular ...
此外,AHA 2024还公布了一项针对FINEARTS-HF研究中非奈利酮对射血分数保留的心衰(HFpEF)/射血分数轻度降低的心衰(HFmrEF)患者血钾水平影响的研究分析[16]。研究结果显示,与安慰剂相比,非奈利酮组患者血钾水平轻微增加(+0.19mmol/L),但这一变化不增加与高钾血症相关的住院风险,且两组均未出现高钾血症相关死亡,...
Related ACC/AHAguidelines include recommendations relevant to HF and,in such cases, the HF guideline refers to these documents.For example, the 2019 primary prevention of cardiovas-cular disease guideline (3) includes recommendationsthat will be useful in preventing HF, and the 2021 valvular...
此外,AHA 2024还公布了一项针对FINEARTS-HF研究中非奈利酮对射血分数保留的心衰(HFpEF)/射血分数轻度降低的心衰(HFmrEF)患者血钾水平影响的研究分析[16]。研究结果显示,与安慰剂相比,非奈利酮组患者血钾水平轻微增加(+0.19mmol/L),但这一变化...
The role of palliative care for patients with heart failure (HF) is discussed in both most recent HF guidelines, the 2021 ESC guideline and the 2022 AHA/ACC/HFSA guideline. This review compares the definitions, concepts and specific recommendations regarding palliative care for patients with HF ...
HFrEF:射血分数降低的心衰;GDMT:指南导向的药物治疗;LVEF:左心室射血分数;ARNi:血管紧张素受体脑啡肽酶抑制剂;NYHA:纽约心脏病协会;ACEI:血管紧张素转换酶抑制剂;ARB:血管紧张素Ⅱ受体拮抗剂;SGLT2i:钠-葡萄糖共转运蛋白2抑制剂;HFimpEF:射血分数改善的心衰;LBBB:左束支传导阻滞;ICD:植入式心脏复律除颤器;CRT...